Medicared For All Logo

Albert Belli JR. DO in Hammonton, New Jersey

Home New Jersey Hammonton

Albert Belli JR. DO has Pulmonary Disease as his primary medical specialty. Their primary office is: 107 Vine St in Hammonton, New Jersey.

They're a part of the: South Jersey Chest Diseases,pa medical group which has around 3 members. You can call their office at 609-561-7666 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Philadelphia College Of Osteopathic Medicine and graduated in 1980 (around 44 years of experience). They are listed as doing telehealth appointments.


Albert J Belli JR. DO Office Phone and Directions

Albert Belli JR. DO
South Jersey Chest Diseases,pa
107 Vine St
Hammonton, New Jersey 08037
609-561-7666


Patient Ratings
Please rate your experience with Albert Belli JR. DO below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 609-561-7666


Enter a starting address:


Healthcare Info for Albert Belli JR. DO

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS), INTERNAL MEDICINE

Medical School: Philadelphia College Of Osteopathic Medicine
Graduation Year: 1980
The Primary Medical Specialty for Albert Belli JR. DO is listed as: Pulmonary Disease
Credentials: DO
Additional Credentials:
Approximate Years of Experience: 44
PAC (PECOS ID)#: 4385692417
NPI #: 1184631012
NPI Created On: 08/02/2006
NPI Last Updated Listed as: 11/22/2011
Primary Taxonomy Code: 207RP1001X
License Number:
MB39383
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • AmeriHealth New Jersey
  • Blue Cross Blue Shield
  • Humana
  • Oscar Garden State Insurance Corporation
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.


Services and Procedures include:

  1. Irrigation and suction of lung airways to obtain cells using an endoscope
  2. Removal of fluid from chest cavity with imaging guidance
  3. Vaccine for influenza for injection into muscle
  4. Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
  5. Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
  6. Exercise test for spasm of lung airways
  7. Determination of lung volumes using plethysmography
  8. Determination of lung volumes using plethysmography
  9. Measurement of lung diffusing capacity
  10. Measurement of lung diffusing capacity
  11. Unattended sleep study with recording of heart rate, oxygen, respiratory airflow and effort
  12. New patient office or other outpatient visit, typically 45 minutes
  13. New patient office or other outpatient visit, typically 60 minutes
  14. Established patient office or other outpatient visit, typically 15 minutes
  15. Established patient office or other outpatient, visit typically 25 minutes
  16. Established patient office or other outpatient, visit typically 40 minutes
  17. Hospital observation care, typically 70 minutes
  18. Initial hospital inpatient care, typically 70 minutes per day
  19. Subsequent observation care, typically 35 minutes per day
  20. Subsequent hospital inpatient care, typically 25 minutes per day

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787536135

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Endo-Mechanical

Name of Drug #1: Monarch Platform


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787965469

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: UPTRAVI

Open Associated Drug #1: 66215-602-14

Drug or Biological: Drug

Product Category #2: Cardiology

Name Of Drug #2:: OPSUMIT

Associated Drug #2: 66215-501-30


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787965471

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: UPTRAVI

Open Associated Drug #1: 66215-602-14

Drug or Biological: Drug

Product Category #2: Cardiology

Name Of Drug #2:: OPSUMIT

Associated Drug #2: 66215-501-30


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787965473

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: UPTRAVI

Open Associated Drug #1: 66215-602-14

Drug or Biological: Drug

Product Category #2: Cardiology

Name Of Drug #2:: OPSUMIT

Associated Drug #2: 66215-501-30


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801892843

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801898975

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802935955

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802944971

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 803081227

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 803115483

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Pulmonary Disease Professionals in Hammonton

107 Vine St
Hammonton, NJ
South Jersey Chest Diseases,pa

107 Vine St
Hammonton, NJ
South Jersey Chest Diseases,pa

Providers in South Jersey Chest Diseases,pa

1.Albert Belli Jr. Do

107 Vine St
Hammonton Nj 08037-1447
South Jersey Chest Diseases,pa
Pulmonary Disease

2.Kevin Gilmour

107 Vine St
Hammonton Nj 08037-1447
South Jersey Chest Diseases,pa
Pulmonary Disease

3.Jack Kanoff

107 Vine St
Hammonton Nj 08037-1447
South Jersey Chest Diseases,pa
Pulmonary Disease

4.Jack Kanoff

525 State Rd
Elmer Nj 08318-2117
South Jersey Chest Diseases,pa
Pulmonary Disease

View all 3 members of South Jersey Chest Diseases,pa medical group